Journal of Diabetes and Its Complications
Volume 24, Issue 2 , Pages 84-89 , March 2010

Factors associated with poor glycemic control among patients with Type 2 diabetes

  • Maysaa Khattab

      Affiliations

    • Faculty of Nursing, Al al-Bayt University, P.O. Box 130040, Mafraq 25113, Jordan
    • ,
  • Yousef S. Khader

      Affiliations

    • Faculty of Medicine, Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan
    • Department of Health and Medical Sciences, Higher Council for Science and Technology, Amman, Jordan
    • Corresponding Author InformationCorresponding author. Tel.: +962 2 795435025; fax: +962 2 7201064.
    • ,
  • Abdelkarim Al-Khawaldeh

      Affiliations

    • National Center for Diabetes, Endocrinology and Genetics, P.O. Box 13165, Amman 11942, Jordan
    • ,
  • Kamel Ajlouni

      Affiliations

    • National Center for Diabetes, Endocrinology and Genetics, P.O. Box 13165, Amman 11942, Jordan

Received 20 October 2008 ,Accepted 22 December 2008.

References 

  1. Ajlouni K, Khader Y, Batieha A, Ajlouni H, EL-khateeb M. An increase in prevalence of diabetes mellitus in Jordan during ten years. Journal of Diabetes and its Complications. 2008;22(5):317–324
  2. Akbar DH. Low rates of diabetic patients reaching good control targets. Eastern Mediterranean Health Journal. 2001, July-September;7(4-5):671–678
  3. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Medical Journal. 2004;25(11):1603–1610
  4. AL-Nuaim AR, Mirdad S, AL-Rubeaan K, et al. Pattern and factors associated with glycemic control of Saudi diabetic patients. Annals of Saudi Medicine. 1998;18(2):109–112
  5. Al-Sultan FA, Al-Zanki N. Clinical epidemiology of Type 2 diabetes mellitus in Kuwait. Kuwait Medical Journal. 2005;37(2):98–104
  6. American Diabetes Association . Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 2003;26:28–32
  7. American Diabetes Association . Dyslipidemia management in adult with diabetes. Diabetes Care. 2004;24:68–71
  8. American Diabetes Association . Standards of Medical Care in Diabetes-2007 (position statement). Diabetes Care. 2007;30:S4–S41
  9. Benoit SR, Fleming R, Tsimikas AP, Ming JI. Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study. BMC Public Health. 2005;5:36–45
  10. Choo PW, Rand CS, Inui TS, Lee MI, Platt R. Validation of patient report, automated pharmacy records, and pill count with electronic monitoring of adherence to anti hypertensive therapy. Medical Care. 1999;37(9):846–857
  11. EL-Kebbi IM, Cook CB, Ziemer DC, et al. Association of younger age with poor glycemic control and obesity in Urban African Americans with Type 2 diabetes. Archives of Internal Medicine. 2003;163:69–75
  12. Ezenwaka CE, Offiah NV. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clinical and Experimental Medicine. 2001;2:91–98
  13. Fitzgerald T, Davis K, Connell M, et al. Development and validation of the diabetes care profile. Evaluation & the Health Professions. 1996;19:208–230
  14. Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with Type 2 diabetes in the United Kingdom general practice research data base: A series of retrospective analysis of data from 1998 through 2002. Clinical Therapeutics. 2006;28(3):388–395
  15. Glasgow E, Maccaul D, Schafer C. Barriers to regimen adherence among person with insulin-dependent diabetes. Journal of Behavioral Medicine. 1986;9(1):65–77
  16. Goudswarrd AN, Stolk RP, Zuithoff P, Rutten G. Patients characteristics do not predict poor glycaemic control in Type 2 diabetes patients treated in primary care. European Journal of Epidemiology. 2004;19:541–545
  17. Habib SS, Aslam M. Risk factors, knowledge and health status in diabetic patients. Saudi Medical Journal. 2003;24(11):1219–1224
  18. International Diabetes Federation . Diabetes Atlas. 2nd ed.. Brussells: International Diabetes Federation; 2003;
  19. Karter AJ, Moffet HH, Liu J, et al. Achieving good glycemic control: Initiation of new anti hyperglycemic therapies in patient with Type 2 diabetes from the Kaiser Permanente Northern California diabetes registry. American Journal of Managed Care. 2005;11:262–270
  20. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type2 diabetes: A preliminary report. Diabetes Care. 2004;27(1):17–20
  21. Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin using adult with Type 2 diabetes. Diabetes Care. 2000;23(3):273–277
  22. Rhee MK, Slocum W, Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educator. 2005;31:240–250
  23. Rothenbacher D, Ruter G, Saam S, Brenner H. Younger patients with Type 2 diabetes need better glycemic control: Results of a community-based study describing factors associated with a high HbA1c value. British Journal of General Practice. 2003;53:389–391
  24. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Annals of Internal Medicine. 2006;144(7):465–474
  25. Saadine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: Quality of care in the 1990's. Annals of Internal Medicine. 2002;136:565–574
  26. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321:405–412
  27. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus . The AACE system of intensive diabetes self-management—2002 update. Endocrine Practice. 2002;8:40–82
  28. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  29. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphanylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet. 1998;352:837–853
  30. Valle T, Koivisto A, Reunanen A, Kangas T, Rissanen A. Glycemic control in patients with diabetes in Finland. Diabetes Care. 1999;22(4):575–579
  31. Verma M, Paneri S, Badi P, Raman G. Effect of increasing duration of diabetes mellitus Type 2 on glycated hemoglobin and insulin sensitivity. Indian Journal of Clinical Biochemistry. 2006;21(1):142–146
  32. Wallace TM, Matthews DR. Poor glycemic control in Type 2 diabetes, conspiracy of disease, suboptimal therapy and attitude. Quarterly Journal of Medicine. 2000;93:369–374
  33. World Health Organization . Physical status: The use and interpretation of anthropometry: Report of a WHO Expert committee. Technical report series 854 Geneva: World Health Organization; 1995;

PII: S1056-8727(08)00129-3

doi: 10.1016/j.jdiacomp.2008.12.008

Journal of Diabetes and Its Complications
Volume 24, Issue 2 , Pages 84-89 , March 2010

Article Tools